# Exploring the Neuroprotective Effects of Hexarelin in Neuro-2A Cells

Canonical source: https://retacompare.com/research/exploring-the-neuroprotective-effects-of-hexarelin-in-neuro-2a-cells

Growth Hormone Peptides · 2021-05-08


    Hexarelin demonstrates significant neuroprotective effects against hydrogen peroxide-induced apoptosis in Neuro-2A cells. This synthetic hexapeptide has been shown to exert cyto-protective effects at the mitochondrial level in both cardiac and skeletal muscle tissues. The implications of these findings extend to potential therapeutic applications in neurodegenerative diseases.

 What this study examined

This study focused on the effects of hexarelin on Neuro-2A cells, a neuroblastoma cell line used as a model for neuronal research. Researchers treated these cells with various concentrations of hydrogen peroxide (H2O2) to induce apoptotic toxicity, followed by treatment with hexarelin. The study measured cell viability, nitrite release, and morphological changes, and evaluated apoptotic responses using Real-Time PCR and Western Blot analyses.

 Why it matters for Hexarelin research

The findings from this study are significant as they highlight hexarelin's potential as a neuroprotective agent. By demonstrating that hexarelin can counteract the damaging effects of oxidative stress, this research opens avenues for further exploration of hexarelin and its analogues in neuroprotection. Understanding the mechanisms through which hexarelin operates could lead to the development of new treatments for conditions characterized by neuronal cell death.

 Key findings

Hexarelin improved cell viability in Neuro-2A cells subjected to H2O2-induced damage.

Treatment with hexarelin reduced nitrite (NO2-) release, indicating decreased oxidative stress.

Hexarelin restored normal cellular morphology in Neuro-2A cells.

Hexarelin treatment decreased mRNA levels of pro-apoptotic factors caspase-3 and caspase-7.

It modulated the expression of BCL-2 family proteins, which are crucial in regulating apoptosis.

Hexarelin inhibited phosphorylation of MAPKs and increased p-Akt protein expression, suggesting a protective signaling pathway.

 How Hexarelin works (background)

Hexarelin is a synthetic hexapeptide that belongs to the growth hormone secretagogue family. Its mechanism of action involves binding to growth hormone secretagogue receptors (GHS-R), which are present in various tissues, including the brain. Upon activation, these receptors stimulate intracellular signaling pathways, notably the MAPK and PI3K/Akt pathways. The activation of these pathways plays a critical role in cell survival, promoting anti-apoptotic mechanisms and enhancing cellular resistance to stressors such as oxidative damage. Previous studies have indicated that peptides like hexarelin can exert protective effects on cardiac and skeletal muscle tissues, and this study extends those findings to neuronal cells.

 Practical takeaways for researchers

For researchers investigating the neuroprotective properties of peptides, hexarelin presents a promising candidate for further study. The modulation of apoptotic pathways and enhancement of cell viability in neuronal models suggest that hexarelin could be beneficial in developing treatments for neurodegenerative diseases. Future research could focus on the development of hexarelin analogues with improved efficacy and specificity for neuronal protection. Additionally, understanding the dosing and timing of hexarelin administration in various models will be crucial for translating these findings into clinical applications.

 FAQ

 What are the primary effects of hexarelin in neuronal cells?

Hexarelin primarily improves cell viability, reduces oxidative stress, and modulates apoptotic pathways in neuronal cells.

 Can hexarelin be used for therapeutic purposes?

While hexarelin shows potential neuroprotective effects, further research is needed to establish its safety and efficacy in clinical settings.

 How does hexarelin compare to other neuroprotective agents?

Hexarelin's unique mechanism involving the modulation of MAPK and PI3K/Akt pathways distinguishes it from other neuroprotective agents, warranting comparative studies.

 Source: PubMed · Pharmaceuticals (Basel) · published 2021-05-08.

## Sources

- PubMed · Pharmaceuticals (Basel): https://pubmed.ncbi.nlm.nih.gov/34066741/